Pfizer (NYSE:PFE) has reached a development milestone related to its undisclosed Consumer Healthcare product which, through the terms of its collaboration with Antares Pharma (ATRS), triggers a $750,000 payment to the latter. Antares licensed to Pfizer’s Consumer Healthcare Business Unit one of its drug delivery techs for the development of an undisclosed product on an exclusive basis for North America in December 2011. In addition, Antares received an upfront payment and will henceforth receive development and sales based milestones along with royalties on net sales for three years after the intro in the United States.
Procter & Gamble (NYSE:PG) is not a buyout or takeover target, according to Bill Ackman of Pershing Square, speaking on CNBC’s Squawk Box. Ackman did criticize the firm’s corporate structure which he called “very fat and very bloated”, which he said has caused it to fall behind its competitors, blaming Chief Executive Robert McDonald personally.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
AT&T (NYSE:T) has finished an upgrade of Subsea 7’s worldwide IP-based virtual private network which in effect doubles the size of its network. The enlarged network will now cover a total of 30 Subsea 7 sites around the world.
Wal-Mart Stores (NYSE:WMT): Toys R Us will offer a price matching guarantee for its toys and products during the holiday shopping season, according to the Associated Press. Competitors’ prices will be matched, assuming that a customer has a current and valid print ad from the store until December 24th. This offer will be valid only in stores.
Don’t Miss: What’s Next for Pfizer?